{"id":"https://openalex.org/W2277757653","doi":"https://doi.org/10.1007/s11899-016-0308-3","title":"Minimal Residual Disease Assessment in the Context of Multiple Myeloma Treatment","display_name":"Minimal Residual Disease Assessment in the Context of Multiple Myeloma Treatment","publication_year":2016,"publication_date":"2016-02-21","ids":{"openalex":"https://openalex.org/W2277757653","doi":"https://doi.org/10.1007/s11899-016-0308-3","mag":"2277757653","pmid":"https://pubmed.ncbi.nlm.nih.gov/26898557","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4819726"},"language":"en","primary_location":{"id":"doi:10.1007/s11899-016-0308-3","doi":"https://doi.org/10.1007/s11899-016-0308-3","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s11899-016-0308-3","pdf_url":"https://link.springer.com/content/pdf/10.1007/s11899-016-0308-3.pdf","source":{"id":"https://openalex.org/S35022943","display_name":"Current Hematologic Malignancy Reports","issn_l":"1558-8211","issn":["1558-8211","1558-822X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Hematologic Malignancy Reports","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://link.springer.com/content/pdf/10.1007/s11899-016-0308-3.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062691289","display_name":"Taiga Nishihori","orcid":"https://orcid.org/0000-0002-2621-7924","observed_orcids":["https://orcid.org/0000-0002-2621-7924"]},"institutions":[{"id":"https://openalex.org/I2613432","display_name":"University of South Florida","ror":"https://ror.org/032db5x82","country_code":"US","type":"education","lineage":["https://openalex.org/I2613432"]},{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Taiga Nishihori","raw_affiliation_strings":["Department of Blood and Marrow Transplantation, Moffitt Cancer Center, Tampa, FL, USA","Department of Oncologic Sciences, Moffitt Cancer Center/University of South Florida Morsani College of Medicine, Tampa, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Blood and Marrow Transplantation, Moffitt Cancer Center, Tampa, FL, USA","institution_ids":["https://openalex.org/I3019308854"]},{"raw_affiliation_string":"Department of Oncologic Sciences, Moffitt Cancer Center/University of South Florida Morsani College of Medicine, Tampa, FL, USA","institution_ids":["https://openalex.org/I2613432","https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017013442","display_name":"Jinming Song","orcid":"https://orcid.org/0000-0001-5642-1451","observed_orcids":["https://orcid.org/0000-0001-5642-1451"]},"institutions":[{"id":"https://openalex.org/I2613432","display_name":"University of South Florida","ror":"https://ror.org/032db5x82","country_code":"US","type":"education","lineage":["https://openalex.org/I2613432"]},{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jinming Song","raw_affiliation_strings":["Department of Hematopathology, Moffitt Cancer Center, Tampa, FL, USA","Department of Oncologic Sciences, Moffitt Cancer Center/University of South Florida Morsani College of Medicine, Tampa, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematopathology, Moffitt Cancer Center, Tampa, FL, USA","institution_ids":["https://openalex.org/I3019308854"]},{"raw_affiliation_string":"Department of Oncologic Sciences, Moffitt Cancer Center/University of South Florida Morsani College of Medicine, Tampa, FL, USA","institution_ids":["https://openalex.org/I2613432","https://openalex.org/I3019308854"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5053572690","display_name":"Kenneth H. Shain","orcid":"https://orcid.org/0000-0003-4178-8888","observed_orcids":["https://orcid.org/0000-0003-4178-8888"]},"institutions":[{"id":"https://openalex.org/I2613432","display_name":"University of South Florida","ror":"https://ror.org/032db5x82","country_code":"US","type":"education","lineage":["https://openalex.org/I2613432"]},{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Kenneth H. Shain","raw_affiliation_strings":["Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, Tampa, FL, 33612, USA. ken.shain@moffitt.org","Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL, USA. ken.shain@moffitt.org","Department of Oncologic Sciences, Moffitt Cancer Center/University of South Florida Morsani College of Medicine, Tampa, FL, USA. ken.shain@moffitt.org","Tumor Biology Department, Moffitt Cancer Center, Tampa, FL, USA. ken.shain@moffitt.org","Department of Oncologic Sciences, Moffitt Cancer Center/University of South Florida Morsani College of Medicine, Tampa, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, Tampa, FL, 33612, USA. ken.shain@moffitt.org","institution_ids":["https://openalex.org/I3019308854"]},{"raw_affiliation_string":"Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL, USA. ken.shain@moffitt.org","institution_ids":["https://openalex.org/I3019308854"]},{"raw_affiliation_string":"Department of Oncologic Sciences, Moffitt Cancer Center/University of South Florida Morsani College of Medicine, Tampa, FL, USA. ken.shain@moffitt.org","institution_ids":["https://openalex.org/I2613432","https://openalex.org/I3019308854"]},{"raw_affiliation_string":"Tumor Biology Department, Moffitt Cancer Center, Tampa, FL, USA. ken.shain@moffitt.org","institution_ids":["https://openalex.org/I3019308854"]},{"raw_affiliation_string":"Department of Oncologic Sciences, Moffitt Cancer Center/University of South Florida Morsani College of Medicine, Tampa, FL, USA","institution_ids":["https://openalex.org/I2613432","https://openalex.org/I3019308854"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5053572690"],"corresponding_institution_ids":["https://openalex.org/I2613432","https://openalex.org/I3019308854"],"apc_list":{"value":3790,"currency":"USD","value_usd":3790},"apc_paid":{"value":3790,"currency":"USD","value_usd":3790},"fwci":0.4717,"has_fulltext":true,"cited_by_count":15,"citation_normalized_percentile":{"value":0.42299189,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"11","issue":"2","first_page":"118","last_page":"126"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/measurable-residual-disease","display_name":"minimal residual disease","score":0.9679999947547913},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":1.0},{"id":"https://openalex.org/keywords/treatment-response-assessment","display_name":"treatment response assessment","score":0.531000018119812},{"id":"https://openalex.org/keywords/proteasome-inhibitors","display_name":"proteasome inhibitors","score":0.8669999837875366},{"id":"https://openalex.org/keywords/monoclonal-antibody-therapy","display_name":"monoclonal antibody therapy","score":0.8420000076293945},{"id":"https://openalex.org/keywords/multiparameter-flow-cytometry","display_name":"multiparameter flow cytometry","score":0.9419999718666077},{"id":"https://openalex.org/keywords/allele-specific-oligonucleotide-pcr","display_name":"allele-specific oligonucleotide PCR","score":0.9739999771118164},{"id":"https://openalex.org/keywords/next-generation-sequencing","display_name":"next-generation sequencing","score":0.9760000109672546},{"id":"https://openalex.org/keywords/imaging-techniques","display_name":"imaging modalities","score":0.8180000185966492},{"id":"https://openalex.org/keywords/treatment-response-criteria","display_name":"treatment response criteria","score":0.5989999771118164}],"concepts":[{"id":"https://openalex.org/C2779823535","wikidata":"https://www.wikidata.org/wiki/Q6865356","display_name":"Minimal residual disease","level":3,"score":0.7648200988769531},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.6964704394340515},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6909984350204468},{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.5773199200630188},{"id":"https://openalex.org/C2779903281","wikidata":"https://www.wikidata.org/wiki/Q6888026","display_name":"Modalities","level":2,"score":0.4669322371482849},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4530175030231476},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4282752275466919},{"id":"https://openalex.org/C19527891","wikidata":"https://www.wikidata.org/wiki/Q1120908","display_name":"Medical physics","level":1,"score":0.3543558418750763},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.34824979305267334},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.33341526985168457},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.3305087685585022},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.13529464602470398},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1197408139705658},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0},{"id":"https://openalex.org/C144024400","wikidata":"https://www.wikidata.org/wiki/Q21201","display_name":"Sociology","level":0,"score":0.0},{"id":"https://openalex.org/C36289849","wikidata":"https://www.wikidata.org/wiki/Q34749","display_name":"Social science","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000483","descriptor_name":"Alleles","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D016133","descriptor_name":"Polymerase Chain Reaction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018365","descriptor_name":"Neoplasm, Residual","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D059014","descriptor_name":"High-Throughput Nucleotide Sequencing","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D064847","descriptor_name":"Multimodal Imaging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1007/s11899-016-0308-3","doi":"https://doi.org/10.1007/s11899-016-0308-3","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s11899-016-0308-3","pdf_url":"https://link.springer.com/content/pdf/10.1007/s11899-016-0308-3.pdf","source":{"id":"https://openalex.org/S35022943","display_name":"Current Hematologic Malignancy Reports","issn_l":"1558-8211","issn":["1558-8211","1558-822X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Hematologic Malignancy Reports","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:3796340","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4819726","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:4819726","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4819726","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Curr Hematol Malig Rep","raw_type":"Text"},{"id":"pmid:26898557","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26898557","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current hematologic malignancy reports","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1007/s11899-016-0308-3","doi":"https://doi.org/10.1007/s11899-016-0308-3","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s11899-016-0308-3","pdf_url":"https://link.springer.com/content/pdf/10.1007/s11899-016-0308-3.pdf","source":{"id":"https://openalex.org/S35022943","display_name":"Current Hematologic Malignancy Reports","issn_l":"1558-8211","issn":["1558-8211","1558-822X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Hematologic Malignancy Reports","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2277757653.pdf","grobid_xml":"https://content.openalex.org/works/W2277757653.grobid-xml"},"referenced_works_count":65,"referenced_works":["https://openalex.org/W49164147","https://openalex.org/W142574250","https://openalex.org/W904214523","https://openalex.org/W1902692042","https://openalex.org/W1984434684","https://openalex.org/W1985012922","https://openalex.org/W1985021407","https://openalex.org/W1988755171","https://openalex.org/W1990372450","https://openalex.org/W1990835696","https://openalex.org/W1991660588","https://openalex.org/W2001779883","https://openalex.org/W2003734726","https://openalex.org/W2006452574","https://openalex.org/W2020214644","https://openalex.org/W2025013606","https://openalex.org/W2028195916","https://openalex.org/W2030093327","https://openalex.org/W2030961727","https://openalex.org/W2032640560","https://openalex.org/W2036142323","https://openalex.org/W2050281367","https://openalex.org/W2056066615","https://openalex.org/W2056206654","https://openalex.org/W2060632341","https://openalex.org/W2079167171","https://openalex.org/W2079278201","https://openalex.org/W2081495071","https://openalex.org/W2086595383","https://openalex.org/W2090310344","https://openalex.org/W2090630520","https://openalex.org/W2092406936","https://openalex.org/W2095384810","https://openalex.org/W2096367061","https://openalex.org/W2096672426","https://openalex.org/W2096909309","https://openalex.org/W2100801413","https://openalex.org/W2123891223","https://openalex.org/W2125721471","https://openalex.org/W2128084036","https://openalex.org/W2139260559","https://openalex.org/W2140930481","https://openalex.org/W2142081242","https://openalex.org/W2146909892","https://openalex.org/W2148758597","https://openalex.org/W2150254829","https://openalex.org/W2155580583","https://openalex.org/W2157369527","https://openalex.org/W2158749770","https://openalex.org/W2165574508","https://openalex.org/W2168109746","https://openalex.org/W2169047291","https://openalex.org/W2171240476","https://openalex.org/W2180166599","https://openalex.org/W2197967010","https://openalex.org/W2201190784","https://openalex.org/W2442012460","https://openalex.org/W2477030112","https://openalex.org/W2527840713","https://openalex.org/W2602265729","https://openalex.org/W2890235308","https://openalex.org/W3086882947","https://openalex.org/W3195431600","https://openalex.org/W4252175385","https://openalex.org/W7075708642"],"related_works":["https://openalex.org/W4200115105","https://openalex.org/W2899835690","https://openalex.org/W3041361317","https://openalex.org/W2048954647","https://openalex.org/W4391103491","https://openalex.org/W3038802153","https://openalex.org/W4210252323","https://openalex.org/W3029531318","https://openalex.org/W4384932161","https://openalex.org/W2989641601"],"abstract_inverted_index":{"With":[0],"contemporary":[1],"therapeutic":[2],"strategies":[3,18],"in":[4,22,43,141],"multiple":[5,25,144],"myeloma,":[6],"heretofore":[7],"unseen":[8],"depth":[9,50],"and":[10,37,77,108,119,122],"rate":[11],"of":[12,24,30,34,48,51,124,138],"responses":[13],"are":[14,91],"being":[15,92],"achieved.":[16],"These":[17],"have":[19],"paralleled":[20],"improvements":[21,42],"outcome":[23],"myeloma":[26,145],"patients.":[27],"The":[28],"integration":[29],"the":[31,46,80,84,116,125],"next":[32],"generation":[33],"proteasome":[35],"inhibitors":[36],"antibody":[38],"therapeutics":[39],"promise":[40],"continued":[41],"therapy":[44,76],"with":[45],"expectation":[47],"consistent":[49],"response":[52,74,81],"not":[53],"quantifiable":[54],"by":[55],"current":[56,126],"clinical":[57],"methods.":[58],"As":[59],"such,":[60],"there":[61],"is":[62],"a":[63],"growing":[64],"need":[65],"to":[66,70,78,128],"develop":[67],"adequate":[68],"tools":[69],"evaluate":[71,120],"deeper":[72],"disease":[73],"after":[75],"refine":[79],"criteria":[82],"including":[83,97],"minimal":[85,130],"residual":[86,131],"disease.":[87,132],"Several":[88],"emerging":[89],"techniques":[90],"evaluated":[93],"for":[94],"these":[95,139],"purposes":[96],"multi-parameter":[98],"flow":[99],"cytometry,":[100],"allele-specific":[101],"oligonucleotide":[102],"polymerase":[103],"chain":[104],"reaction,":[105],"next-generation":[106],"sequencing,":[107],"imaging":[109],"modalities.":[110],"In":[111],"this":[112],"review,":[113],"we":[114],"highlight":[115],"recent":[117],"developments":[118],"advantages":[121],"limitations":[123],"technologies":[127],"assess":[129],"We":[133],"also":[134],"discuss":[135],"future":[136],"applications":[137],"methodologies":[140],"potentially":[142],"guiding":[143],"treatment":[146],"decisions.":[147]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}